306 related articles for article (PubMed ID: 33505404)
1. Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis-Translation of Pathogenic Fundamentals Into an
Braegelmann C; Fetter T; Niebel D; Dietz L; Bieber T; Wenzel J
Front Immunol; 2020; 11():622511. PubMed ID: 33505404
[TBL] [Abstract][Full Text] [Related]
2. Type I Immune Response Induces Keratinocyte Necroptosis and Is Associated with Interface Dermatitis.
Lauffer F; Jargosch M; Krause L; Garzorz-Stark N; Franz R; Roenneberg S; Böhner A; Mueller NS; Theis FJ; Schmidt-Weber CB; Biedermann T; Eyerich S; Eyerich K
J Invest Dermatol; 2018 Aug; 138(8):1785-1794. PubMed ID: 29526761
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulatory Endogenous Nucleic Acids Drive the Lesional Inflammation in Cutaneous Lupus Erythematosus.
Scholtissek B; Zahn S; Maier J; Klaeschen S; Braegelmann C; Hoelzel M; Bieber T; Barchet W; Wenzel J
J Invest Dermatol; 2017 Jul; 137(7):1484-1492. PubMed ID: 28351661
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the profile of the immune cell infiltrate in lichen planus, discoid lupus erythematosus, and chronic dermatitis.
Hussein MR; Aboulhagag NM; Atta HS; Atta SM
Pathology; 2008 Dec; 40(7):682-93. PubMed ID: 18728929
[TBL] [Abstract][Full Text] [Related]
5. Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.
Fetter T; Smith P; Guel T; Braegelmann C; Bieber T; Wenzel J
Front Immunol; 2020; 11():344. PubMed ID: 32194562
[TBL] [Abstract][Full Text] [Related]
6. Clinical perspectives and murine models of lichenoid tissue reaction/interface dermatitis.
Okiyama N; Fujimoto M
J Dermatol Sci; 2015 Jun; 78(3):167-72. PubMed ID: 25813248
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
[TBL] [Abstract][Full Text] [Related]
8. [Mucocutaneous diseases and murine models with death of keratinocytes induced by lichenoid tissue reaction/interface dermatitis].
Okiyama N
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):1-7. PubMed ID: 25765683
[TBL] [Abstract][Full Text] [Related]
9. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease.
Bennion SD; Middleton MH; David-Bajar KM; Brice S; Norris DA
J Invest Dermatol; 1995 Jul; 105(1 Suppl):71S-79S. PubMed ID: 7616001
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus.
Zahn S; Rehkämper C; Kümmerer BM; Ferring-Schmidt S; Bieber T; Tüting T; Wenzel J
J Invest Dermatol; 2011 Jan; 131(1):133-40. PubMed ID: 20720564
[TBL] [Abstract][Full Text] [Related]
11. Nucleic Acid Immunity in the Pathogenesis of Cutaneous Lupus Erythematosus.
Günther C
Front Immunol; 2019; 10():1636. PubMed ID: 31379837
[TBL] [Abstract][Full Text] [Related]
12. An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis".
Wenzel J; Tüting T
J Invest Dermatol; 2008 Oct; 128(10):2392-402. PubMed ID: 18418411
[TBL] [Abstract][Full Text] [Related]
13. Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives.
Sontheimer RD
J Invest Dermatol; 2009 May; 129(5):1088-99. PubMed ID: 19242512
[TBL] [Abstract][Full Text] [Related]
14. NKG2D and its ligands as cytotoxic factors in cutaneous lupus erythematosus.
Vorwerk G; Zahn S; Bieber T; Wenzel J
Exp Dermatol; 2021 Jun; 30(6):847-852. PubMed ID: 33687107
[TBL] [Abstract][Full Text] [Related]
15. Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis.
Garelli CJ; Refat MA; Nanaware PP; Ramirez-Ortiz ZG; Rashighi M; Richmond JM
Front Immunol; 2020; 11():1353. PubMed ID: 32714331
[TBL] [Abstract][Full Text] [Related]
16. Lupus erythematosus/lichen planus overlap syndrome: successful treatment with acitretin.
Lospinoso DJ; Fernelius C; Edhegard KD; Finger DR; Arora NS
Lupus; 2013 Jul; 22(8):851-4. PubMed ID: 23761099
[TBL] [Abstract][Full Text] [Related]
17. Coexisting lichen planus and subacute cutaneous lupus erythematosus.
Grabbe S; Kolde G
Clin Exp Dermatol; 1995 May; 20(3):249-54. PubMed ID: 7671426
[TBL] [Abstract][Full Text] [Related]
18. Activation of Innate Immunity by Therapeutic Nucleic Acids.
Bishani A; Chernolovskaya EL
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948156
[TBL] [Abstract][Full Text] [Related]
19. Lichenoid tissue reaction/interface dermatitis: recognition, classification, etiology, and clinicopathological overtones.
Sehgal VN; Srivastava G; Sharma S; Sehgal S; Verma P
Indian J Dermatol Venereol Leprol; 2011; 77(4):418-29; quiz 430. PubMed ID: 21727689
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
Panter G; Kuznik A; Jerala R
Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
